KAUFMAN, MICHAEL D.,FLYNN, DANIEL L,AHN, YU MI,VOGETI, LAKSHMINARAYANA,CALDWELL, TIMOTHY MALCOLM
申请号：
EP14764032
公开号：
EP2968286A4
申请日:
2014.03.14
申请国别(地区):
EP
年份:
2016
代理人:
摘要：
Described are compounds of Formula I which find utility in the treatment of cancer, autoimmune diseases and metabolic bone disorders through inhibition of c-FMS (CSF-1R), c-KIT, and/or PDGFR kinases. These compounds also find utility in the treatment of other mammalian diseases mediated by c-FMS, c-KIT, or PDGFR kinases.
